Page 2 - Lpcn News Today

StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Sunday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance LPCN opened at $2.47 on Friday. The business’s 50-day moving average is $2.78 and its two-hundred day moving average is $3.90. Lipocine […]

StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note released on Sunday morning. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Shares of NASDAQ LPCN opened at $2.51 on Friday. The company has a 50-day moving average price of $2.81 and a […]

By Emon Reiser Lipocine said the results of its Phase 2 study evaluating LPCN 1148, a treatment to manage decompensated cirrhosis, will be presented at the...

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report released on Saturday morning. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of Lipocine stock opened at $2.79 on Friday. The stock has a 50-day moving average price of $3.66 and a […]

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Friday. The brokerage issued a sell rating on the specialty pharmaceutical company’s stock. Lipocine Price Performance Lipocine stock opened at $2.96 on Friday. The company has a market cap of $15.75 million, a price-to-earnings ratio of -1.24 and a […]

StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note issued to investors on Thursday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Up 5.3 % Shares of Lipocine stock opened at $2.98 on Thursday. The stock’s 50-day simple moving average is $4.13 and […]

StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research report report published on Wednesday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 1.5 % Shares of NASDAQ:LPCN opened at $3.34 on Wednesday. The company has a 50 day moving average of $4.27 and […]

StockNews.com began coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a report published on Wednesday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 6.1 % Shares of NASDAQ LPCN opened at $3.22 on Wednesday. The business’s 50 day moving average is $4.31 and its two-hundred […]

StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Free Report) in a research note published on Tuesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 4.0 % Shares of Lipocine stock opened at $3.64 on Tuesday. Lipocine has a 52 week low of $3.30 and a 52 […]

EP Wealth Advisors LLC purchased a new position in Lipocine Inc. (NASDAQ:LPCN – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 66,983 shares of the specialty pharmaceutical company’s stock, valued at approximately $13,395,000. A number of other institutional investors have […]